Mark Kerschner is an Angel Investor, a strategic advisor, a finance advisory committee member and an independent board member of various organizations. He began his career with PWC in NYC and now has been utilizing his experience as a CFO of both public and private companies, working in the chemicals, engineering and pharma industries. Currently he serves as a Board member and Senior Advisor of Seneca Therapeutics, Inc.
Mark is presently a member of Broad Street Angels, Keiretsu Mid-Atlantic and Mid-Atlantic Bio Angels.